Lotus Pharm vs SynCore Biotechnology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and SynCore Biotechnology (4192) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ SynCore Biotechnology

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYSynCore BiotechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$2 million-0.3%
Sep 2026NT$2.77 billion+128.0%NT$2 million+7.0%
Aug 2026NT$2.11 billion+81.7%NT$1.8 million-12.0%
Jul 2026NT$2.49 billion+3.9%NT$2.2 million-12.3%
Jun 2026NT$3.4 billion+225.5%NT$1.6 million-22.5%
May 2026NT$2.32 billion+105.8%NT$2.7 million-18.7%
Apr 2026NT$3.09 billion+19.9%NT$1.9 million-18.6%
Mar 2026NT$4.35 billion+173.6%NT$2.1 million-4.6%
Feb 2026NT$2.24 billion+131.5%NT$1.9 million+33.9%
Jan 2026NT$2.05 billion-5.5%NT$2.1 million+20.8%
Dec 2025NT$2.44 billion+66.9%NT$2.7 million-12.3%
Nov 2025NT$1.06 billion-0.2%NT$2.7 million+43.7%
Oct 2025NT$2.75 billion+46.0%NT$2 million+20.7%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16